Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Howe

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Molecular Pathology : MP|April 16, 1998
Heterogeneity of clonal lymphocytes with regard to bcl-2 protein concentration and cell sizeT J Bromidge, D J Howe, S A Johnson, et al.
Leukemia|August 11, 1998
In vitro chemosensitivity of chronic lymphocytic leukaemia to purine analogues--correlation with clinical courseT J Bromidge, D L Turner, D J Howe, et al.
Leukemia & Lymphoma|October 1, 1995
Tetrasomy of chromosome 8 in a patient with acute myeloid leukemiaG M Cull, D J Howe, M Stack-Dunne, et al.
The Journal of Biological Chemistry|May 27, 1994
A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-beta ligandsC H Bassing, D J Howe, P R Segarini, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1995
Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanismM B Datto, Y Li, J F Panus, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Molecular complete response in a patient with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosineG Cull, D S Richardson, D J Howe, et al.
Hematology (Amsterdam, Netherlands)|July 14, 2016
Trisomy 12 is a Rare Event in Cases of CLL with Typical Immunophenotype and MorphologyD J Howe, T J Bromidge, M Stack-Dunne, et al.
Science (New York, N.Y.)|January 7, 1994
A transforming growth factor beta type I receptor that signals to activate gene expressionC H Bassing, J M Yingling, D J Howe, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Molecular Pathology : MP|April 16, 1998
Heterogeneity of clonal lymphocytes with regard to bcl-2 protein concentration and cell sizeT J Bromidge, D J Howe, S A Johnson, et al.
Leukemia|August 11, 1998
In vitro chemosensitivity of chronic lymphocytic leukaemia to purine analogues--correlation with clinical courseT J Bromidge, D L Turner, D J Howe, et al.
Leukemia & Lymphoma|October 1, 1995
Tetrasomy of chromosome 8 in a patient with acute myeloid leukemiaG M Cull, D J Howe, M Stack-Dunne, et al.
The Journal of Biological Chemistry|May 27, 1994
A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-beta ligandsC H Bassing, D J Howe, P R Segarini, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1995
Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanismM B Datto, Y Li, J F Panus, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1995
Molecular complete response in a patient with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosineG Cull, D S Richardson, D J Howe, et al.
Hematology (Amsterdam, Netherlands)|July 14, 2016
Trisomy 12 is a Rare Event in Cases of CLL with Typical Immunophenotype and MorphologyD J Howe, T J Bromidge, M Stack-Dunne, et al.
Science (New York, N.Y.)|January 7, 1994
A transforming growth factor beta type I receptor that signals to activate gene expressionC H Bassing, J M Yingling, D J Howe, et al.
Pageof 2